Return on Tangible Equity (Quarterly)

Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity

Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (BORAY) had Return on Tangible Equity of 0.45% for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$126.44M
Net Income	$0.82M
Cost of Goods Sold	$80.85M
Gross Profit	$45.59M
Operating Expenses	$113.57M
Operating Income	$12.87M
Non-Operating Income/Expense	$-5.88M
Pre-Tax Income	$6.99M
Normalized Pre-Tax Income	$6.99M
Income after Taxes	$1.48M
Income from Continuous Operations	$1.48M
Consolidated Net Income/Loss	$1.03M
Normalized Income after Taxes	$1.48M
EBIT	$12.87M
EBITDA	$21.36M
Weighted-Average Shares Outstanding (Basic)	636.45M
Weighted-Average Shares Outstanding (Diluted)	658.25M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$626.07M
Property, Plant, and Equipment	$335.43M
Long-Term Assets	$806.41M
Total Assets	$1.43B
Current Liabilities	$453.07M
Long-Term Debt	$389.29M
Long-Term Liabilities	$453.94M
Total Liabilities	$907.02M
Common Equity	$525.47M
Tangible Shareholders Equity	$329.37M
Shareholders Equity	$525.47M
Common Shares Outstanding	638.67M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$20.09M
Cash Flow from Investing Activities	$-14.82M
Cash Flow from Financial Activities	$-17.40M
Beginning Cash	$160.43M
End Cash	$152.69M
Increase/Decrease in Cash	$-7.74M
Stock-Based Compensation	$0.56M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.38
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.43
Debt to Equity Ratio	1.01
Gross Margin	36.05%
Operating Margin	10.18%
EBIT Margin	10.18%
EBITDA Margin	--
Pre-Tax Profit Margin	5.53%
Profit Margin	0.65%
Free Cash Flow	$13.44M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	0.69
Receiveable Turnover	0.41
Days Sales in Receivables	216.90
Return on Equity	0.28%
Return on Tangible Equity	0.45%
Return on Assets	0.10%
Return on Investments	0.16%
Book Value Per Share	$0.82
Free Cash Flow per Share	$0.02
Operating Cash Flow per Share	$0.03

Data from Zacks Investment Research, Inc.